Takasaki K, Chou S
Adv Exp Med Biol. 2024; 1459:261-287.
PMID: 39017848
DOI: 10.1007/978-3-031-62731-6_12.
Liao R, Bresnick E
Exp Hematol. 2024; 137:104252.
PMID: 38876253
PMC: 11381147.
DOI: 10.1016/j.exphem.2024.104252.
Dolberg T, Gunnels T, Ling T, Sarnese K, Crispino J, Leonard J
ACS Synth Biol. 2024; 13(4):1273-1289.
PMID: 38536408
PMC: 11536268.
DOI: 10.1021/acssynbio.3c00754.
Katsumura K, Liu P, Kim J, Mehta C, Bresnick E
Proc Natl Acad Sci U S A. 2024; 121(10):e2317147121.
PMID: 38422019
PMC: 10927522.
DOI: 10.1073/pnas.2317147121.
Wang X, Liu S, Yu J
Adv Exp Med Biol. 2024; 1442:159-175.
PMID: 38228964
DOI: 10.1007/978-981-99-7471-9_10.
Pathogenic human variant that dislocates GATA2 zinc fingers disrupts hematopoietic gene expression and signaling networks.
Jung M, Shen S, Botten G, Olender T, Katsumura K, Johnson K
J Clin Invest. 2023; 133(7).
PMID: 36809258
PMC: 10065080.
DOI: 10.1172/JCI162685.
Lineage-specific, fast-evolving GATA-like gene regulates zygotic gene activation to promote endoderm specification and pattern formation in the Theridiidae spider.
Iwasaki-Yokozawa S, Nanjo R, Akiyama-Oda Y, Oda H
BMC Biol. 2022; 20(1):223.
PMID: 36203191
PMC: 9535882.
DOI: 10.1186/s12915-022-01421-0.
Two Isoforms of Containing Either One or Two GATA Zinc Fingers Provide Functional Diversity During Development.
Moussalem D, Auge B, Di Stefano L, Osman D, Gobert V, Haenlin M
Front Cell Dev Biol. 2022; 9:795680.
PMID: 35178397
PMC: 8844375.
DOI: 10.3389/fcell.2021.795680.
Therapeutic targeting of the inflammasome in myeloid malignancies.
Chakraborty S, Shapiro L, de Oliveira S, Rivera-Pena B, Verma A, Shastri A
Blood Cancer J. 2021; 11(9):152.
PMID: 34521810
PMC: 8440507.
DOI: 10.1038/s41408-021-00547-8.
Human GATA2 mutations and hematologic disease: how many paths to pathogenesis?.
Bresnick E, Jung M, Katsumura K
Blood Adv. 2020; 4(18):4584-4592.
PMID: 32960960
PMC: 7509867.
DOI: 10.1182/bloodadvances.2020002953.
Constructing and deconstructing GATA2-regulated cell fate programs to establish developmental trajectories.
Johnson K, Conn D, Shishkova E, Katsumura K, Liu P, Shen S
J Exp Med. 2020; 217(11).
PMID: 32736380
PMC: 7596813.
DOI: 10.1084/jem.20191526.
GATA1 mutations in red cell disorders.
Ling T, Crispino J
IUBMB Life. 2019; 72(1):106-118.
PMID: 31652397
PMC: 7323890.
DOI: 10.1002/iub.2177.
Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1.
Zhang J, Ali A, Lieu Y, Liu Z, Gao J, Rabadan R
Mol Cell. 2019; 76(1):82-95.e7.
PMID: 31474574
PMC: 7065273.
DOI: 10.1016/j.molcel.2019.07.017.
Blood disease-causing and -suppressing transcriptional enhancers: general principles and mechanisms.
Bresnick E, Johnson K
Blood Adv. 2019; 3(13):2045-2056.
PMID: 31289032
PMC: 6616255.
DOI: 10.1182/bloodadvances.2019000378.
Deubiquitylase USP7 regulates human terminal erythroid differentiation by stabilizing GATA1.
Liang L, Peng Y, Zhang J, Zhang Y, Roy M, Han X
Haematologica. 2019; 104(11):2178-2187.
PMID: 30872372
PMC: 6821630.
DOI: 10.3324/haematol.2018.206227.
The Pleiotropic Effects of GATA1 and KLF1 in Physiological Erythropoiesis and in Dyserythropoietic Disorders.
Barbarani G, Fugazza C, Strouboulis J, Ronchi A
Front Physiol. 2019; 10:91.
PMID: 30809156
PMC: 6379452.
DOI: 10.3389/fphys.2019.00091.
Transcription factor mutations as a cause of familial myeloid neoplasms.
Churpek J, Bresnick E
J Clin Invest. 2019; 129(2):476-488.
PMID: 30707109
PMC: 6355228.
DOI: 10.1172/JCI120854.
Human leukemia mutations corrupt but do not abrogate GATA-2 function.
Katsumura K, Mehta C, Hewitt K, Soukup A, Fraga de Andrade I, Ranheim E
Proc Natl Acad Sci U S A. 2018; 115(43):E10109-E10118.
PMID: 30301799
PMC: 6205465.
DOI: 10.1073/pnas.1813015115.
GATA/Heme Multi-omics Reveals a Trace Metal-Dependent Cellular Differentiation Mechanism.
Tanimura N, Liao R, Wilson G, Dent M, Cao M, Burstyn J
Dev Cell. 2018; 46(5):581-594.e4.
PMID: 30122630
PMC: 6133724.
DOI: 10.1016/j.devcel.2018.07.022.
Mechanisms of erythrocyte development and regeneration: implications for regenerative medicine and beyond.
Bresnick E, Hewitt K, Mehta C, Keles S, Paulson R, Johnson K
Development. 2018; 145(1).
PMID: 29321181
PMC: 5825862.
DOI: 10.1242/dev.151423.